259 related articles for article (PubMed ID: 17214852)
1. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
2. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
[TBL] [Abstract][Full Text] [Related]
3. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
4. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease.
Liu H; Moroi Y; Yasumoto S; Kokuba H; Imafuku S; Koga T; Masuda T; Tu Y; Furue M; Urabe K
Br J Dermatol; 2006 Sep; 155(3):586-91. PubMed ID: 16911286
[TBL] [Abstract][Full Text] [Related]
6. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
[TBL] [Abstract][Full Text] [Related]
8. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
9. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Cutan Pathol; 2009 Apr; 36(4):402-8. PubMed ID: 19278424
[TBL] [Abstract][Full Text] [Related]
10. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
13. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
Smith KJ; Tuur S; Corvette D; Lupton GP; Skelton HG
Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
[TBL] [Abstract][Full Text] [Related]
16. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
18. Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease.
Shan SJ; Zhang N; Geng SL; Zhou Z; Chen X; Nie T; Guo Z; Li C; Liu Q; Guo Y; Wei H; Chen HD
J Cutan Pathol; 2010 Jun; 37(6):635-40. PubMed ID: 19788441
[TBL] [Abstract][Full Text] [Related]
19. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.
Hatta N; Yamada M; Hirano T; Fujimoto A; Morita R
Br J Dermatol; 2008 Feb; 158(2):313-8. PubMed ID: 18028492
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
